A data science roadmap for open science organizations engaged in early-stage drug discovery
Kristina Edfeldt(Karolinska University Hospital), Matthieu Schapira(University of Toronto), Brian D. Marsden(Centre for Human Genetics), A.M. Edwards(University of Toronto), David G. Hulcoop(European Bioinformatics Institute), Judith Günther(Bayer (Germany)), Andrew R. Leach(LifeArc), Djork-Arné Clevert(Bayer (Germany)), Dafydd R. Owen(Pfizer (United States)), Matthew Hartley(European Bioinformatics Institute), Nicholas J. Skelton(Scripps Research Institute), Susanne Müller(Goethe University Frankfurt), James Wellnitz(University of North Carolina at Chapel Hill), Ola Engkvist(AstraZeneca (Australia)), Alexander Tropsha(University of North Carolina at Chapel Hill), Erik Vernet, Timothy M. Willson(University of North Carolina at Chapel Hill), Kristof T. Schütt(Pfizer (Germany)), Leonie Misquitta(National Institutes of Health), Yanli Wang(Zhejiang Sci-Tech University), Andreas Steffen(Pfizer (Germany)), Lovisa Holmberg Schiavone(AstraZeneca (Japan)), Amelie Menge(Goethe University Frankfurt), Benjamin Haibe‐Kains(University of Toronto)
Cited by 24
Related Papers
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
|Journal of Molecular Biology|1997|6.7k
ChEMBL: towards direct deposition of bioassay data
|Nucleic Acids Research|2018|2.5k
The ChEMBL database in 2017
|Nucleic Acids Research|2016|2.4k
Molecular Modelling: Principles and Applications
|Unknown|1996|1.9k
Quantum-chemical insights from deep tensor neural networks
|Nature Communications|2017|1.5k